Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2018 Filed Nov 27, 2018 18:16 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 1,778 | $3.45 | $6,131.97 |
DisclosureSEC source: 0001437749-18-021314 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as director of Skywords Family Foundation Inc.(1) Disclosed balance after: 310,081 Read SEC document |
| November 19, 2018 Filed Nov 19, 2018 18:48 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 251 | $3.40 | $853.48 |
DisclosureSEC source: 0001437749-18-021098 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as director of Skywords Family Foundation Inc.(1) Disclosed balance after: 308,303 Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 18:48 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 8,052 | $3.53 | $28,430.00 |
DisclosureSEC source: 0001437749-18-021098 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as director of Skywords Family Foundation Inc.(1) Disclosed balance after: 308,052 Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 13:49 UTC |
Meridian OHC Partners, LP10% owner
Meridian TSV II, LP10% owner
TSV Investment Partners, LLC10% owner
BlueLine Capital Partners II, L.P.10% owner
BlueLine Partners, L.L.C.10% owner
|
OtherCommon Stock | 100,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-18-001201 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,116 F1 · ownership.direct: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity. F2 · ownership.direct: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 17:28 UTC |
Vied David LDirector
|
GrantCyanotech Corporation Common Stock | 10,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-016356 · rdgdoc.xml · nonDerivative · entry 1 Vied David L · CIK 0001632792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,105 Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 17:32 UTC |
KATZ NANCY EDirector
|
GrantCyanotech Corporation Common Stock | 8,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-016358 · rdgdoc.xml · nonDerivative · entry 1 KATZ NANCY E · CIK 0001189692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,556 Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 17:30 UTC |
MULDER DAVID MDirector
|
GrantCyanotech Corporation Common Stock | 8,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-016357 · rdgdoc.xml · nonDerivative · entry 1 MULDER DAVID M · CIK 0001208781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,556 Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 17:26 UTC |
Menzel Walter BennettDirector
|
GrantCyanotech Corporation Common Stock | 10,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-016355 · rdgdoc.xml · nonDerivative · entry 1 Menzel Walter Bennett · CIK 0001586458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,845 Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 17:25 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-016354 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 450,225 Read SEC document |
| July 13, 2018 Filed Jul 18, 2018 15:00 UTC |
Cysewski Gerald RDirector · CSO
|
GrantRestricted stock units · Derivative | 2,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013432 · rdgdoc.xml · derivative · entry 3 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,210 Underlying: Cyanotech common stock · 2,210 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 737 shares on July 13, 2019, 737 shares on July 13, 2020 and 736 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 737 shares on July 13, 2019, 737 shares on July 13, 2020 and 736 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| July 13, 2018 Filed Jul 18, 2018 14:58 UTC |
Morton MawaeDirector · CEO
|
GrantRestricted stock units · Derivative | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013430 · rdgdoc.xml · derivative · entry 1 Morton Mawae · CIK 0001715607 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959 Underlying: Cyanotech common stock · 1,959 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 653 shares on July 13, 2019, 653 shares on July 13, 2020, and 653 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 653 shares on July 13, 2019, 653 shares on July 13, 2020, and 653 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| July 13, 2018 Filed Jul 18, 2018 14:55 UTC |
Johansen Jennifer M.VP of Quality
|
GrantRestricted stock units · Derivative | 1,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013426 · rdgdoc.xml · derivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,305 Underlying: Cyanotech common stock · 1,305 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 435 shares on July 13, 2019, 435 shares on July 13, 2020 and 435 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 435 shares on July 13, 2019, 435 shares on July 13, 2020 and 435 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| July 13, 2018 Filed Jul 18, 2018 14:47 UTC |
Deal Jole EileenCFO, VP, Treasurer, Secretary
|
GrantRestricted stock units · Derivative | 2,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013418 · rdgdoc.xml · derivative · entry 2 Deal Jole Eileen · CIK 0001528404 · CFO, VP, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026 Underlying: Cyanotech common stock · 2,026 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 676 shares on July 13, 2019, 675 shares on July 13, 2020 and 675 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 676 shares on July 13, 2019, 675 shares on July 13, 2020 and 675 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| July 13, 2018 Filed Jul 18, 2018 14:44 UTC | GrantRestricted stock units · Derivative | 2,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013415 · rdgdoc.xml · derivative · entry 2 WATTS GERARD J · CIK 0001251119 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,238 Underlying: Cyanotech common stock · 2,238 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 746 shares on July 13, 2019, 746 shares on July 13, 2020 and 746 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 746 shares on July 13, 2019, 746 shares on July 13, 2020 and 746 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
|
| July 13, 2018 Filed Jul 18, 2018 14:42 UTC |
Jensen GlennVP of Manufacturing
|
GrantRestricted stock units · Derivative | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013411 · rdgdoc.xml · derivative · entry 3 Jensen Glenn · CIK 0001369173 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505 Underlying: Cyanotech common stock · 1,505 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 502 shares on July 13, 2019, 502 shares on July 13, 2020 and 501 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 502 shares on July 13, 2019, 502 shares on July 13, 2020 and 501 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 15:04 UTC |
Jensen GlennVP of Manufacturing
|
Exercise / conversionRestricted stock units · Derivative | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006546 · rdgdoc.xml · derivative · entry 9 Jensen Glenn · CIK 0001369173 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333 Underlying: Cyanotech common stock · 167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F8 · derivative.exercise_date: The restricted stock units shall vest as to 167 shares on 4/5/2019 and 166 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. F8 · derivative.expiration_date: The restricted stock units shall vest as to 167 shares on 4/5/2019 and 166 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 15:04 UTC |
Jensen GlennVP of Manufacturing
|
Tax withholdingCyanotech common stock | 63 | $5.25 | $330.75 |
DisclosureSEC source: 0001437749-18-006546 · rdgdoc.xml · nonDerivative · entry 2 Jensen Glenn · CIK 0001369173 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,437 F1 · kind: The reporting person is reporting the withholding by the Issuer of 63 shares of common stock that vested on April 5, 2018 pursuant to the April 5, 2017 RSU grant, but that were not issued in order to satisfy the reporting person's tax withholding obligations in connection with the delivery of the converted common stock to the reporting person as of April 6, 2018. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 15:04 UTC |
Jensen GlennVP of Manufacturing
|
Exercise / conversionCyanotech common stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006546 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 15:01 UTC |
Deal Jole EileenCFO, VP, Treasurer, Secretary
|
Disposition to issuerRestricted stock units · Derivative | 101 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006543 · rdgdoc.xml · derivative · entry 2 Deal Jole Eileen · CIK 0001528404 · CFO, VP, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203 Underlying: Cyanotech common stock · 101 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 101 shares on April 5, 2018, 101 shares on April 5, 2019 and 102 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 101 shares on April 5, 2018, 101 shares on April 5, 2019 and 102 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 15:01 UTC |
Deal Jole EileenCFO, VP, Treasurer, Secretary
|
Exercise / conversionCyanotech common stock | 101 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006543 · rdgdoc.xml · nonDerivative · entry 1 Deal Jole Eileen · CIK 0001528404 · CFO, VP, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:57 UTC |
Johansen Jennifer M.VP of Quality
|
Exercise / conversionRestricted stock units · Derivative | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006538 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333 Underlying: Cyanotech common stock · 167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 167 shares on 4/5/2019 and 166 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 167 shares on 4/5/2019 and 166 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:57 UTC |
Johansen Jennifer M.VP of Quality
|
Tax withholdingCyanotech common stock | 63 | $5.25 | $330.75 |
DisclosureSEC source: 0001437749-18-006538 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,109 F8 · kind: The reporting person is reporting the withholding by the Issuer of 63 shares of common stock that vested on April 5, 2018 pursuant to the April 5, 2017 RSU grant, but that were not issued in order to satisfy the reporting person's tax withholding obligations in connection with the delivery of the converted common stock to the reporting person as of April 6, 2018. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:57 UTC |
Johansen Jennifer M.VP of Quality
|
Exercise / conversionCyanotech common stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006538 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:58 UTC | Exercise / conversionRestricted stock units · Derivative | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006541 · rdgdoc.xml · derivative · entry 4 WATTS GERARD J · CIK 0001251119 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113 Underlying: Cyanotech common stock · 57 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 57 shares on 4/5/2019 and 56 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 57 shares on 4/5/2019 and 56 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
|
| April 05, 2018 Filed Apr 9, 2018 14:58 UTC | Tax withholdingCyanotech common stock | 22 | $5.25 | $115.50 |
DisclosureSEC source: 0001437749-18-006541 · rdgdoc.xml · nonDerivative · entry 2 WATTS GERARD J · CIK 0001251119 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35 F1 · kind: The reporting person is reporting the withholding by the Issuer of 22 shares of common stock that vested on April 5, 2018 pursuant to the April 5, 2017 RSU grant, but that were not issued in order to satisfy the reporting person's tax withholding obligations in connection with the delivery of the converted common stock to the reporting person as of April 6, 2018. Read SEC document |
|
| April 05, 2018 Filed Apr 9, 2018 14:58 UTC | Exercise / conversionCyanotech common stock | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006541 · rdgdoc.xml · nonDerivative · entry 1 WATTS GERARD J · CIK 0001251119 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| April 05, 2018 Filed Apr 9, 2018 14:55 UTC |
Morton MawaeDirector · CEO
|
GrantRestricted stock units · Derivative | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006535 · rdgdoc.xml · derivative · entry 2 Morton Mawae · CIK 0001715607 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67 Underlying: Cyanotech common stock · 67 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 5, 2019 and 34 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 5, 2019 and 34 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:53 UTC |
Cysewski Gerald RDirector · CSO
|
Exercise / conversionRestricted stock units · Derivative | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006533 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333 Underlying: Cyanotech common stock · 167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 167 shares on April 5, 2018, 167 shares on April 5, 2019 and 166 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 167 shares on April 5, 2018, 167 shares on April 5, 2019 and 166 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:53 UTC |
Cysewski Gerald RDirector · CSO
|
Tax withholdingCyanotech common stock | 63 | $5.25 | $330.75 |
DisclosureSEC source: 0001437749-18-006533 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,959 F5 · kind: The reporting person is reporting the withholding by the issuer of 63 shares of common stock that vested on April 5, 2018 pursuant to the April 5, 2017 RSU grant, but that were not issued in order to satisfy the reporting person's tax withholding obligations in connection with the delivery of the converted common stock to the reporting person as of April 6, 2018. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:53 UTC |
Cysewski Gerald RDirector · CSO
|
Exercise / conversionCyanotech common stock | 167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006533 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 14:11 UTC |
Cysewski Gerald RDirector · CSO
|
Exercise / conversionRestricted stock units · Derivative | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006320 · rdgdoc.xml · derivative · entry 5 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Cyanotech common stock · 8,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F3 · derivative.exercise_date: The restricted stock units shall vest as to 8,333 shares on March 31, 2018, 8,333 on March 31, 2019 and 8,334 on March 31, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F3 · derivative.expiration_date: The restricted stock units shall vest as to 8,333 shares on March 31, 2018, 8,333 on March 31, 2019 and 8,334 on March 31, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 14:11 UTC |
Cysewski Gerald RDirector · CSO
|
Tax withholdingCyanotech common stock | 3,130 | $5.10 | $15,963.00 |
DisclosureSEC source: 0001437749-18-006320 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,855 F5 · kind: The reporting person is reporting the withholding by the issuer of 3,130 shares of common stock that vested on March 31, 2018 pursuant to the March 31, 2017 RSU grant, but that were not issued in order to satisfy the reporting persons tax withholding obligations in connection with the delivery of the converted common stock to the reporting person as of April 2, 2018. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 14:11 UTC |
Cysewski Gerald RDirector · CSO
|
Exercise / conversionCyanotech common stock | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006320 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 15:55 UTC |
Cysewski Gerald RDirector · CSO
|
Exercise / conversionCyanotech common stock options · Derivative | 2,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001437749-18-003225 · rdgdoc.xml · derivative · entry 3 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Cyanotech common stock · 2,000 shares Expires 2018-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 15:55 UTC |
Cysewski Gerald RDirector · CSO
|
Exercise / conversionCyanotech common stock | 2,000 | $1.60 | $3,200.00 |
DisclosureSEC source: 0001437749-18-003225 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2018 Filed Jan 24, 2018 18:58 UTC |
Morton MawaeDirector · CEO
|
GrantCyanotech common stock options · Derivative | 45,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001437749-18-001095 · rdgdoc.xml · derivative · entry 1 Morton Mawae · CIK 0001715607 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Cyanotech common stock · 45,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The stock options shall vest as to 15,000 shares on January 24, 2019, 15,000 shares on January 24, 2020 and 15,000 shares on January 24, 2021, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| December 04, 2017 Filed Jan 5, 2018 13:41 UTC |
Jensen GlennVP of Manufacturing
|
Exercise / conversionCyanotech common stock options · Derivative | 2,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001437749-18-000320 · rdgdoc.xml · derivative · entry 3 Jensen Glenn · CIK 0001369173 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Cyanotech common stock · 2,000 shares Expires 2018-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Mr Jensen acquired 2,000 stock options on 2/22/2008, of which 200 options became exercisable on 2/22/2009, 400 options became exercisable on 2/22/2010, 600 options became exercisable on 2/22/2011 and 800 options became exercisable on 2/22/2012. Read SEC document |
| December 04, 2017 Filed Jan 5, 2018 13:41 UTC |
Jensen GlennVP of Manufacturing
|
Exercise / conversionCyanotech Corporation Common Stock | 2,000 | $1.60 | $3,200.00 |
DisclosureSEC source: 0001437749-18-000320 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP of Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 16:22 UTC |
Vied David LDirector
|
GrantCyanotech Corporation Common Stock | 17,021 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-015328 · rdgdoc.xml · nonDerivative · entry 1 Vied David L · CIK 0001632792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,903 Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 16:21 UTC |
MULDER DAVID MDirector
|
GrantCyanotech Corporation Common Stock | 11,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-015327 · rdgdoc.xml · nonDerivative · entry 1 MULDER DAVID M · CIK 0001208781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,915 Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 16:20 UTC |
Menzel Walter BennettDirector
|
GrantCyanotech Corporation Common Stock | 16,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-015325 · rdgdoc.xml · nonDerivative · entry 1 Menzel Walter Bennett · CIK 0001586458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,635 Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 16:18 UTC |
KATZ NANCY EDirector
|
GrantCyanotech Corporation Common Stock | 6,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-015324 · rdgdoc.xml · nonDerivative · entry 1 KATZ NANCY E · CIK 0001189692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,809 Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 16:17 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 6,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-015322 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 442,025 Read SEC document |
| August 24, 2017 Filed Oct 31, 2017 15:03 UTC Amendment |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-017950 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 441,892 F1 · shares: Due to a clerical error, the number of shares acquired was previously misreported as 6,383 shares in the reporting person's Form 4 filed on August 25, 2017. Read SEC document |
| August 24, 2017 Filed Oct 31, 2017 14:55 UTC Amendment |
Vied David LDirector
|
GrantCyanotech Corporation Common Stock | 16,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-017946 · rdgdoc.xml · nonDerivative · entry 1 Vied David L · CIK 0001632792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,549 F1 · shares: Due to a clerical error, the number of shares acquired was previously misreported as 17,021 shares in the reporting person's Form 4 filed on August 25, 2017. Read SEC document |
| August 24, 2017 Filed Oct 31, 2017 14:52 UTC Amendment |
MULDER DAVID MDirector
|
GrantCyanotech Corporation Common Stock | 11,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-017944 · rdgdoc.xml · nonDerivative · entry 1 MULDER DAVID M · CIK 0001208781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,667 F1 · shares: Due to a clerical error, the number of shares acquired was previously misreported as 11,915 shares in the reporting person's Form 4 filed on August 25, 2017. Read SEC document |
| August 24, 2017 Filed Oct 31, 2017 14:47 UTC Amendment |
KATZ NANCY EDirector
|
GrantCyanotech Corporation Common Stock | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-017942 · rdgdoc.xml · nonDerivative · entry 1 KATZ NANCY E · CIK 0001189692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 F1 · shares: Due to a clerical error, the number of shares acquired was previously misreported as 6,809 shares in the reporting person's Form 4 filed on August 25, 2017. Read SEC document |
| August 24, 2017 Filed Nov 6, 2017 14:42 UTC Amendment |
Menzel Walter BennettDirector
|
GrantCyanotech Corporation Common Stock | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-018397 · rdgdoc.xml · nonDerivative · entry 1 Menzel Walter Bennett · CIK 0001586458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,289 F1 · shares: Due to a clerical error, the number of shares acquired was previously misreported as 16,596 shares in the reporting person's Form 4 filed on August 25, 2017. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 14:17 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GiftCyanotech Corporation Common Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-015204 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as director of Skywords Family Foundation Inc.(1) Disclosed balance after: 300,000 Read SEC document |
| July 14, 2017 Filed Aug 29, 2017 17:22 UTC |
Morton MawaePresident
|
GrantCyanotech common stock options · Derivative | 75,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001437749-17-015412 · rdgdoc.xml · derivative · entry 1 Morton Mawae · CIK 0001715607 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Cyanotech common stock · 75,000 shares Expires 2027-07-14 F1 · derivative.exercise_date: The stock options shall vest as to 25,000 shares on July 14, 2018, 25,000 shares on July 14, 2019 and 25,000 shares on July 14, 2020, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.